Sulfonylurea antidiabetics are associated with lower risk of out-of-hospital cardiac arrest: Real-world data from a population-based study.
Talip E ErogluLixia JiaMarieke T BlomArie O VerkerkHarsha D DevallaGerard J J BoinkPatrick C SouvereinAnthonius de BoerHanno L TanPublished in: British journal of clinical pharmacology (2021)
SU drugs were associated with reduced OHCA risk compared to metformin monotherapy, with gliclazide having a lower risk than glimepiride. The differential effects of SU drugs are not explained by differential effects on APD.